GR76842B - - Google Patents

Info

Publication number
GR76842B
GR76842B GR68483A GR820168483A GR76842B GR 76842 B GR76842 B GR 76842B GR 68483 A GR68483 A GR 68483A GR 820168483 A GR820168483 A GR 820168483A GR 76842 B GR76842 B GR 76842B
Authority
GR
Greece
Application number
GR68483A
Inventor
William Lesley Matter
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of GR76842B publication Critical patent/GR76842B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
GR68483A 1981-06-23 1982-06-18 GR76842B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,465 US4455317A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
GR76842B true GR76842B (el) 1984-09-04

Family

ID=23056760

Family Applications (1)

Application Number Title Priority Date Filing Date
GR68483A GR76842B (el) 1981-06-23 1982-06-18

Country Status (18)

Country Link
US (1) US4455317A (el)
EP (1) EP0081581B1 (el)
JP (1) JPS58500995A (el)
AU (1) AU558475B2 (el)
CA (1) CA1176987A (el)
CH (1) CH655443B (el)
DE (1) DE3248837T1 (el)
EG (1) EG16713A (el)
ES (4) ES8405358A1 (el)
GB (1) GB2112786B (el)
GR (1) GR76842B (el)
IL (1) IL66071A (el)
IT (1) IT1156373B (el)
NL (1) NL8220253A (el)
NZ (1) NZ200973A (el)
PH (1) PH18764A (el)
WO (1) WO1983000015A1 (el)
ZA (1) ZA824341B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
JP4241926B2 (ja) 1995-10-10 2009-03-18 ウィリアム ジョン ルイス 3―アミノ―プロポキシフェニル誘導体(1)
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
US7678829B2 (en) * 2004-05-25 2010-03-16 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
JPS49247A (el) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
FR2208653A2 (en) * 1972-12-06 1974-06-28 Orsymonde Cardiac antiarrhythmic phloroglucinol ethers - of hydroxy alkylaminoalkanoic acids
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0003664B1 (en) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
EP0053434B1 (en) * 1980-11-28 1986-08-27 American Hospital Supply Corporation Compounds and method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
ES513388A0 (es) 1984-06-01
AU558475B2 (en) 1987-01-29
NZ200973A (en) 1986-04-11
AU8737082A (en) 1983-01-18
GB2112786B (en) 1986-02-19
IT1156373B (it) 1987-02-04
ES8507468A1 (es) 1985-09-01
ES8507469A1 (es) 1985-09-01
ES8405358A1 (es) 1984-06-01
IL66071A (en) 1986-09-30
CA1176987A (en) 1984-10-30
GB2112786A (en) 1983-07-27
PH18764A (en) 1985-09-20
WO1983000015A1 (en) 1983-01-06
IT8267794A0 (it) 1982-06-22
EP0081581A1 (en) 1983-06-22
NL8220253A (nl) 1983-05-02
ES530209A0 (es) 1985-09-01
ES530207A0 (es) 1985-09-01
ES530208A0 (es) 1985-09-01
JPS58500995A (ja) 1983-06-23
IL66071A0 (en) 1982-09-30
EG16713A (en) 1990-10-30
DE3248837T1 (de) 1983-12-01
ZA824341B (en) 1983-04-27
US4455317A (en) 1984-06-19
GB8303062D0 (en) 1983-03-09
ES8507467A1 (es) 1985-09-01
CH655443B (el) 1986-04-30
EP0081581A4 (en) 1983-11-21
EP0081581B1 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
DE3249628A1 (el)
DE3277546D1 (el)
DE3242899C2 (el)
DE3226186C2 (el)
DE3212884C2 (el)
FR2499297B1 (el)
DE3153330C2 (el)
DE3214552C2 (el)
DE3222098C2 (el)
DE3104404C2 (el)
IN155197B (el)
CH655469B (el)
DE3220494C2 (el)
DE3134367C2 (el)
GR76842B (el)
FR2499222B3 (el)
FR2497864B3 (el)
DE3226145C2 (el)
DE3223790C2 (el)
FR2497987B1 (el)
FR2498014B3 (el)
FR2512515B1 (el)
DE3107472C2 (el)
JPS57195361U (el)
DE3102852C2 (el)